Skip to content

Multicentric observational study on Pediatric Multisystem Inflammatory Syndrome (PMIS) related to Covid-19

Covid-19 associated Pediatric Multisystem Inflammatory syndrome (PMIS): A multicentric observational clinical study from Delhi

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/11/029030
Enrollment
100
Registered
2020-11-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

Dr Dhiren Gupta
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Fever > 38â??C for >=24 hours in last 7 days 2. Evidence of clinically severe hospitalized illness among children aged =2) organ involvement (cardiac, renal, respiratory, hematologic, gastrointestinal, dermatologic or neurological) see table for definitions used for organ involvement. 3. Elevated markers of inflammation (eg, neutrophilia; lymphopenia; hypoalbuminemia; and elevated levels of C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), fibrinogen, procalcitonin, d-dimer, ferritin, lactic acid dehydrogenase (LDH), or interleukin 6 (IL-6)] 4. No other obvious microbial cause of inflammation, including bacterial sepsis and staphylococcal/streptococcal toxic shock syndromes 5. Evidence of SARS-CoV-2 infection (Any of the following): 5.1. Positive SARS-CoV-2 RT-PCR 5.2. Positive serology 5.3. Positive antigen test 5.4. Negative for SARS-CoV-2 RT-PCR and antibody tests but with identified COVID-19 exposure within the four weeks prior to the onset of symptoms

Exclusion criteria

Exclusion criteria: 1. Hospital stay 2. Presence of other obvious microbiological cause of inflammation/ clinical condition

Design outcomes

Primary

MeasureTime frame
MortalityTimepoint: At the time of discharge from hospital

Secondary

MeasureTime frame
Demographics, Clinical symptoms, clinical examination findings, Laboratory values, treatment modalities usedTimepoint: 6 months

Countries

India

Contacts

Public ContactDr Bharat Mehra

Max super-speciality hospital, Shalimar Bagh

bharatmehra909@gmail.com9999538720

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026